FDA 21 CFR Part 11 for Banking & Capital Markets
What FDA 21 CFR Part 11 means for Banking & Capital Markets organizations — and how we implement it at the architecture level.
FDA 21 CFR Part 11 in Banking & Capital Markets environments carries requirements that go beyond the framework's general provisions. The specific operations of Banking & Capital Markets organizations — their data processing scale, their regulatory relationships, and their operational dependencies — create compliance obligations that engineering teams must address at the architecture level. Generic FDA 21 CFR Part 11 compliance that ignores the Banking & Capital Markets context will produce a system that passes audit by a framework-generalist but fails review by an industry-specialist examiner.
Our teams deploy in Banking & Capital Markets environments with FDA 21 CFR Part 11 compliance built into the architecture from the first design decision. The compliance controls are not a layer added to an existing system — they are implemented as first-class components that generate evidence continuously as the system operates. The result is a system that is compliant on deployment day, remains compliant as it evolves, and produces audit evidence without manual assembly.
FDA 21 CFR Part 11 compliance documentation maintained as live system artifacts, not annual documentation projects
Access controls that satisfy FDA 21 CFR Part 11 requirements for Banking & Capital Markets data handling
Audit logging that generates evidence meeting FDA 21 CFR Part 11 audit standards in Banking & Capital Markets regulatory contexts
Incident response procedures aligned to FDA 21 CFR Part 11 notification and reporting timelines
Third-party vendor compliance documentation satisfying FDA 21 CFR Part 11 supply chain requirements
We implement FDA 21 CFR Part 11 compliance for Banking & Capital Markets clients by mapping the framework's requirements to the specific operational context of Banking & Capital Markets organizations before writing application code. Controls are implemented through infrastructure-as-code, enforced automatically by ALICE at every commit, and documented through automated evidence generation pipelines. The result is a FDA 21 CFR Part 11-compliant Banking & Capital Markets system delivered on a fixed-price timeline.
Ready to build FDA 21 CFR Part 11 compliance into your Banking & Capital Markets system?
We build compliance architecture for Banking & Capital Markets organizations — FDA 21 CFR Part 11 and the full Banking & Capital Markets compliance landscape — from the first infrastructure decision. Fixed price. Production delivery. No discovery phase.